ApprovalTrail

Approval · Notice of Compliance 6187 · 2001

PROPOFLO INJECTION: Notice of Compliance 6187

Issued September 25, 2001

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6187
Date
September 25, 2001
Company
Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Anesthetic

Products in this notice

BrandDINStatus today
PROPOFLO INJECTION02244685Cancelled Post Market

Medicinal ingredients